Decreasing risk of viral transfusion-transmitted diseases in Croatia

Croatian Medical Journal

Volumn 41, Issue 2, 2000, Pages 191-196

  Grgičević, Damir ^a   Balija, Melita ^a   Pirc Tiljak, Dubravka ^a   Mihaljević, Ivanka ^a   Gjenero Margan, Ira ^b   Župančić Šalek, Silva ^c   Macek, Pavel ^d  

^a CROATIAN INSTITUTE OF TRANSFUSION MEDICINE   (Croatia)

^b CROATIAN NATIONAL INSTITUTE OF PUBLIC HEALTH   (Croatia)

^c UNIVERSITY OF ZAGREB   (Croatia)

^d Croatia   (Croatia)

Author keywords

AIDS; Blood banks; Blood donors; Blood transfusion; Croatia; Hepatitis B; Hepatitis C; HPV seropositivity; Syphilis

Indexed keywords

HEPATITIS B SURFACE ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; BLEEDING DISORDER; BLOOD BANK; BLOOD DONOR; BLOOD TRANSFUSION; CROATIA; HEMOPHILIA; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MAJOR CLINICAL STUDY; SYPHILIS; VIRUS TRANSMISSION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; BLOOD TRANSFUSION; CROATIA; HEPATITIS B; HEPATITIS C; HUMANS; SYPHILIS; VIRUS DISEASES;

EID: 1642633548     PISSN: 03539504     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Isbister JP. Risk management in transfusion medicine. Transfus Med Rev 1996;10:183-202.
2. Grgičević D, Vuk T. A perception of transfusion safety. Acta Med Croat 1998;52:165-70.
3. AuBuchon JP, Kruskall MS. Transfusion safety: realigning efforts with risks. Transfusion 1997; 37:1211-6.
4. Douay L, Debeir J, and others from de Reseau d'Hemovigilance. Le bilan du reseau d'Hemovigilance au 1/10/97. La Gazette de la Transfusion 1998; 19:39-52.
5. Cash JD. Uses and hazards of blood transfusion: a selective uptake. Proc R Coll Phys Edin 1994;24:527-33.
6. Zuck TE Greeting a final look back with comments about a policy of a zero-risk blood supply. Transfusion 1987;27:447-8.
7. Republic of Croatia. Pravilnik o krvi i krvnim sastojcima [Guidelines on blood and blood components]. Narodne novine 1999;14:412-21.
8. Roblee JA, Crosby E. Transfusion medicine issues in the practice of anesthesiology. Transfus Med Rev 1995;9:60-78.
9. Nichols MD. Quality assurance of hospital transfusion practices. Med J Austr 1993;158:295-7.
10. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. The risk of transfusion-transmitted viral infections. N Engl J Med 1996;334:1685-9.
11. Courouce AM, Pillonell J, for the Retrovirus and Viral Hepatitis Working Groups of the French Society of Blood Transfusion. Transfusion-Transmitted viral infections. N Engl J Med 1996;335:1609-10.
12. Soldan K, Barbara J. The risks of infection transmission by blood transfusion in England. J Clin Pathol 1999;52:405-8.
13. AuBuchon JP. Blood transfusion options: improving outcomes and reducing costs. Arch Pathol Lab Med 1997;121:40-7.
14. Goodnough LT, Brecher ME, Kanter MH, AuBuchon JP. Blood transfusion. N Engl J Med 1999;340:438-47.
15. Van der Poel C, Noel L, Barbara J, Dodd R. ISBT Working Party on Transmissible Diseases: report on the workshop Infectious Disease Testing and Quality Control. Vox Sang 1996;70:53-60.
16. Council of Experts on Blood Transfusion and Immunohaematology (Sp-HM). Infectious disease markers - 1995. Strasbourg: Council of Europe; SP-HM (97) 5, 1998.
17. Nalpas B, Desenclos JC, Delaroque-Astagneau, Drucker J. State of epidemiological knowledge and national management of hepatitis C virus infection in the European Community, 1996. Eur J Pub Health 1998;8:305-12.
18. Council of Europe. Recommendation on the preparation use and quality assurance of blood components (R15). Strasbourg: Council of Europe Press; 1998.
19. WHO, UNAIDS. Report on global HIV/AIDS epidemic. AIDS epidemic update. Geneva: WHO; December 1998.
20. Lee CA. Transfusion-transmitted disease. Baillieres Clin Haematol "Haemophilia" 1996;9:369-94.
21. Eyster ME, Diamond-Stone LS, Lien JM, Ehmann WC, Quan S, Goedert JJ, for the Multicenter Hemophilia Cohort Study: Hepatitis C virus and human immunodeficiency virus in multitransfused hemophiliacs: effect of coinfection with human immunodeficiency virus. J Acquir Immune Defic Syndr 1993;6:602-10.
22. Grgičević D, Flego I, Marchiotti I, Lupret Lj, Rajninger-Miholić M. Ispitivanje aktivnosti faktora VIII:C tokom postupka toplinske inaktivacije virusa u krioprecipitatu. Liječ Vjesn 1990;112:212-5.
23. Lee DH, Paling JE, Blajchman MA. A new tool for communicating transfusion risk information. Transfusion 1998;38:184-8.
24. Calman KC. Cancer: science and society and the communication of risks. BMJ 1996;313:799-802.